| p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells RJ Ihry, KA Worringer, MR Salick, E Frias, D Ho, K Theriault, S Kommineni, ... Nature medicine 24 (7), 939-946, 2018 | 942 | 2018 |
| Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss H Liu, J Golji, LK Brodeur, FS Chung, JT Chen, RS deBeaumont, ... Nature medicine 25 (1), 95-102, 2019 | 252 | 2019 |
| TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts AL Grauel, B Nguyen, D Ruddy, T Laszewski, S Schwartz, J Chang, ... Nature communications 11 (1), 6315, 2020 | 122 | 2020 |
| P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells RJ Ihry, KA Worringer, MR Salick, E Frias, D Ho, K Theriault, S Kommineni, ... bioRxiv, 168443, 2017 | 57 | 2017 |
| Postoperative radiation therapy for osseous metastasis: Outcomes and predictors of local failure ZD Epstein-Peterson, A Sullivan, M Krishnan, JT Chen, M Ferrone, ... Practical Radiation Oncology 5 (5), e531-e536, 2015 | 31 | 2015 |
| Exquisite sensitivity to dual BRG1/BRM ATPase inhibitors reveals broad SWI/SNF dependencies in acute myeloid leukemia F Rago, LU Rodrigues, M Bonney, K Sprouffske, E Kurth, GN Elliott, ... Molecular cancer research 20 (3), 361-372, 2022 | 24 | 2022 |
| Automated Scale-up and Maintenance of Stem Cell-Induced Neurons for Long-Term Culture and High-Throughput Screening J Ambrose, F Mapa, N Ross, J Chen, C Ye, B Bilican SLAS Technology, 2017 | | 2017 |
| P53 toxicity is 1 stem cells. 2 SK Theriault, J Chen, M Sondey, C Ye, R Randhawa, GR Forrester, ... stem cells 2, 3, 0 | | |
